Lilly shares safety, tolerability data on its next-gen obesity drug
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Revolution Medicines’ pancreatic cancer drug proving hard to get
Amy Johnston is distraught and readily admits that she is “grasping at straws.” Diagnosed last year with pancreatic…
New hormone protocol cut relapse risk in prostate cancer trial
Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of…
Revolution Medicines starts early access for pancreatic cancer drug
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
CVS restores Zepbound coverage, adds Eli Lilly’s obesity pill Foundayo
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on…
Eli Lilly: Single-shot gene therapy lowered cholesterol in early study
Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in…
What to expect at Trump Jr.-backed ‘Steroid Olympics’ this Sunday
A new sports competition featuring Olympic medalists will take place in Las Vegas on Sunday. The twist? The…
Lilly’s triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial
In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with…
White House adds generic drugs to direct-to-consumer TrumpRx site
President Donald Trump speaks to introduce the TrumpRx website in the South Court Auditorium of the White House…
Hantavirus cases spark surge in pharma, biotech stocks — here’s why
ILLUSTRATION of hantavirus testing concept with laboratory tubes containing cotton swabs and HANTAVIRUS labels photographed in front of…
FDA withdrew studies finding Covid, shingles vaccines were safe
The FDA blocked the publication of several studies supporting the safety of vaccines against Covid and shingles in…
Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalent of Ozempic®
TORONTO, May 1, 2026 /PRNewswire/ – Apotex Inc. (“Apotex” or the “Company”), Canada’s largest Canadian‑based global health company,…